Aurinia Pharmaceuticals
AUPH
AUPH
61 hedge funds and large institutions have $151M invested in Aurinia Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
62% less call options, than puts
Call options by funds: $896K | Put options by funds: $2.36M
Holders
61
Holding in Top 10
1
Calls
$896K
Puts
$2.36M
Top Buyers
| 1 | +$3.42M | |
| 2 | +$2.52M | |
| 3 | +$969K | |
| 4 |
D.E. Shaw & Co
New York
|
+$852K |
| 5 |
Rockefeller Capital Management
New York
|
+$625K |
Top Sellers
| 1 | -$2M | |
| 2 | -$812K | |
| 3 | -$549K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$517K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$460K |